What is the threshold for reporting prescriptions under the Delaware PMP?

The threshold for reporting prescriptions under the Delaware Prescription Monitoring Program (PMP) is that any dispensing of a controlled substance must be reported. This requirement ensures that all medications classified as controlled substances are tracked, providing valuable data to healthcare providers and regulatory bodies. By monitoring the dispensing of these substances, the PMP aims to prevent misuse and over-prescribing, fostering better prescribing practices and enhancing patient safety.

The emphasis on reporting any controlled substance includes not only opioids but also other medications that fall under various schedules regulated by state and federal law. This comprehensive approach helps create a wider scope of oversight in monitoring trends in prescription use across different types of controlled substances, not limiting the data to specific categories or settings. Overall, this policy is crucial for addressing issues related to substance abuse and ensuring responsible medication management within the healthcare system.